Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kelly-Anne Phillips

Showing results (51-60 of 143) with videos related to

Pageof 15
Sort By:
Breast Cancer Research and Treatment|June 19, 2013
Using SNP genotypes to improve the discrimination of a simple breast cancer risk prediction modelGillian S Dite, Maryam Mahmoodi, Adrian Bickerstaffe, et al.
Australian Journal of Primary Health|February 24, 2015
Transitioning to routine breast cancer risk assessment and management in primary care: what can we learn from cardiovascular disease?Kelly-Anne Phillips, Emma J Steel, Ian Collins, et al.
Breast (Edinburgh, Scotland)|July 8, 2014
Assessing and managing breast cancer risk: clinicians' current practice and future needsIan M Collins, Emma Steel, G Bruce Mann, et al.
The Lancet. Oncology|August 2, 2005
What survival benefits do premenopausal patients with early breast cancer need to make endocrine therapy worthwhile?Belinda Thewes, Bettina Meiser, Vlatka M Duric, et al.
Breast (Edinburgh, Scotland)|April 14, 2010
Cognitive function in postmenopausal women receiving adjuvant letrozole or tamoxifen for breast cancer in the BIG 1-98 randomized trialKelly-Anne Phillips, Karin Ribi, Zhuoxin Sun, et al.
Breast Cancer Research and Treatment|November 4, 2010
Cognitive function in postmenopausal breast cancer patients one year after completing adjuvant endocrine therapy with letrozole and/or tamoxifen in the BIG 1-98 trialKelly-Anne Phillips, Julie Aldridge, Karin Ribi, et al.
BMJ Open|June 18, 2025
Evaluation of a telehealth service to support breast cancer prevention medication uptake: a protocol of a mixed methods studyKatrina Louise West, Tim Spelman, Wanda Cui, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 28, 2007
Cancer risk management practices of noncarriers within BRCA1/2 mutation positive families in the Kathleen Cuningham Foundation Consortium for Research into Familial Breast CancerSarah-Jane Dawson, Melanie A Price, Mark A Jenkins, et al.
Familial Cancer|June 14, 2005
Predictors of participation in clinical and psychosocial follow-up of the kConFab breast cancer family cohortKelly-Anne Phillips, Phyllis N Butow, Ailsa E Stewart, et al.
Breast Cancer Research and Treatment|February 9, 2010
Past recreational physical activity, body size, and all-cause mortality following breast cancer diagnosis: results from the Breast Cancer Family RegistryTheresa H M Keegan, Roger L Milne, Irene L Andrulis, et al.
Pageof 15

Showing results (51-60 of 143) with videos related to

Sort By:
Pageof 15
Breast Cancer Research and Treatment|June 19, 2013
Using SNP genotypes to improve the discrimination of a simple breast cancer risk prediction modelGillian S Dite, Maryam Mahmoodi, Adrian Bickerstaffe, et al.
Australian Journal of Primary Health|February 24, 2015
Transitioning to routine breast cancer risk assessment and management in primary care: what can we learn from cardiovascular disease?Kelly-Anne Phillips, Emma J Steel, Ian Collins, et al.
Breast (Edinburgh, Scotland)|July 8, 2014
Assessing and managing breast cancer risk: clinicians' current practice and future needsIan M Collins, Emma Steel, G Bruce Mann, et al.
The Lancet. Oncology|August 2, 2005
What survival benefits do premenopausal patients with early breast cancer need to make endocrine therapy worthwhile?Belinda Thewes, Bettina Meiser, Vlatka M Duric, et al.
Breast (Edinburgh, Scotland)|April 14, 2010
Cognitive function in postmenopausal women receiving adjuvant letrozole or tamoxifen for breast cancer in the BIG 1-98 randomized trialKelly-Anne Phillips, Karin Ribi, Zhuoxin Sun, et al.
Breast Cancer Research and Treatment|November 4, 2010
Cognitive function in postmenopausal breast cancer patients one year after completing adjuvant endocrine therapy with letrozole and/or tamoxifen in the BIG 1-98 trialKelly-Anne Phillips, Julie Aldridge, Karin Ribi, et al.
BMJ Open|June 18, 2025
Evaluation of a telehealth service to support breast cancer prevention medication uptake: a protocol of a mixed methods studyKatrina Louise West, Tim Spelman, Wanda Cui, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 28, 2007
Cancer risk management practices of noncarriers within BRCA1/2 mutation positive families in the Kathleen Cuningham Foundation Consortium for Research into Familial Breast CancerSarah-Jane Dawson, Melanie A Price, Mark A Jenkins, et al.
Familial Cancer|June 14, 2005
Predictors of participation in clinical and psychosocial follow-up of the kConFab breast cancer family cohortKelly-Anne Phillips, Phyllis N Butow, Ailsa E Stewart, et al.
Breast Cancer Research and Treatment|February 9, 2010
Past recreational physical activity, body size, and all-cause mortality following breast cancer diagnosis: results from the Breast Cancer Family RegistryTheresa H M Keegan, Roger L Milne, Irene L Andrulis, et al.
Pageof 15